Larry Johnston
Family Medicine · Albertville, ALNPI 1023003019
Payments from drug & device makers
Across 384 payments — averaging $14.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- GSK$898
- Lilly USA, LLC$390
- AstraZeneca$364
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$340
- Amgen$310
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,454100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 110 | $1,302 |
| GSK | 58 | $898 |
| Lilly USA, LLC | 27 | $390 |
| AstraZeneca | 25 | $364 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $340 |
| Amgen | 19 | $310 |
| Amarin Pharma, Inc. | 17 | $280 |
| Pfizer | 15 | $224 |
| Merck | 11 | $216 |
| Novo Nordisk | 15 | $206 |
| Sanofi-aventis U.S. LLC | 8 | $119 |
| Sunovion Pharmaceuticals Inc. | 14 | $96 |
| Eisai Inc. | 5 | $78 |
| Novartis | 4 | $76 |
| Corium, LLC | 4 | $56 |
| Dexcom, Inc. | 3 | $54 |
| Biohaven Pharmaceuticals, Inc. | 2 | $46 |
| Astellas Pharma US Inc | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Orexo US, Inc. | 3 | $38 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Genentech USA, Inc. | 2 | $33 |
| Bayer | 2 | $28 |
| Boehringer Ingelheim | 2 | $25 |
| Antares Pharma, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $19 |
| Mylan Specialty L.p. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Medtronic | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Clarus Therapeutics Inc. | 1 | $7 |
How this compares
$5,454 in reported general payments places this provider in the 80th percentile of 1,680 family medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 33 | $39,999 |
| JardianceEmpagliflozin | 34 | $36,865 |
| TrulicityDulaglutide | 23 | $31,880 |
| XareltoRivaroxaban | 19 | $14,634 |
| EliquisApixaban | 14 | $10,376 |
| Victoza 3-PakLiraglutide | 11 | $8,786 |
| LinzessLinaclotide | 14 | $8,551 |
| MyrbetriqMirabegron | 13 | $8,304 |
| BrilintaTicagrelor | 16 | $5,387 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $4,444 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $2,054 |
| Atorvastatin Calcium | 144 | $1,384 |
| Omeprazole | 97 | $1,372 |
| Gabapentin | 79 | $1,263 |
| Rosuvastatin Calcium | 73 | $1,223 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $216 | $39,99933 claims |
| Boehringer IngelheimJardiance | $25 | $36,86534 claims |
| Lilly USA, LLCTrulicity, Humalog | $390 | $32,77236 claims |
| PfizerEliquis | $224 | $10,37614 claims |
| AbbVieLinzess | $1,302 | $8,55114 claims |
| Astellas Pharma US IncMyrbetriq | $46 | $8,30413 claims |
| AstraZenecaBrilinta | $364 | $5,38716 claims |
| Sanofi-aventis U.S. LLCLantus | $119 | $1,10211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Albertville
- Michael PetersAlbertville$17K
- Roan GannonAlbertville$17K
- Michael VaughnBirmingham$9.9M
- William NixonGuntersville$7.1M
- Randall QuinnCullman$5.4M
- Matthew CaldwellAthens$4.1M
- Michael CarterHuntsville$3.4M
- Howard RubensteinSaraland$3.3M
- Randle MiddletonHuntsville$3.3M
- Aaron KarrSheffield$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.